Pappas C G, Paddock H, Goyette P, Grabowy R, Connolly R J, Schwaitzberg S D
Department of Surgery, New England Medical Center, Boston, MA 02111, USA.
Crit Care Med. 1995 Jul;23(7):1243-50. doi: 10.1097/00003246-199507000-00015.
To verify two hypotheses: a) In-line microwave warming of cold in-date packed red blood cells (RBCs) does not produce significant hemolysis; and b) in-line microwave warming achieves higher outlet temperatures as compared with current blood warming technology at high flow rates (> 250 mL/min).
Multiple part, randomized, controlled study.
Surgical research laboratory of a large university medical center.
Twenty-four units of cold, ready for transfusion in-date packed RBCs ranging in storage age from 6 to 16 days.
Part I: Microwave apparatus outlet, warmed vs. unwarmed. Six units of cold packed RBCs was split into paired samples and infused at 13 mL/min through a 700-watt in-line microwave test apparatus. One paired specimen was warmed to 37 degrees C; the other was infused without warming (control). Blood was analyzed at the outlet. Part II: Microwave and countercurrent warming, inlet vs. outlet. Twelve units of cold packed RBCs was analyzed biochemically both before (inlet) and after (outlet) simulated transfusions. Six units was infused through a 900-watt in-line microwave test apparatus at > 500 mL/min. Six separate cold units were warmed at this rate using single channel countercurrent water bath warming. Part III: Microwave and countercurrent technology, inlet vs. outlet, warmed vs. unwarmed. a) Six units of cold packed RBCs was also analyzed biochemically and infused at 5 mL/min through either a microwave or countercurrent water bath warmer. b) Packed RBCs from the units used in part a) were allowed to remain stationary in the microwave heating cartridge for 15 mins with an activated heating element. Parallel stationary flow studies were done using the countercurrent blood warmer. Control unwarmed samples were also tested.
Part I: No statistical differences in hemolysis parameters were observed between microwave warmed and unwarmed packed RBCs. Part II: At high-flow rates, no statistical increases in hemolysis parameters were seen after in-line microwave or countercurrent water bath warming as compared with prewarmed cold controls. Part III: At slow-flow rates, nonstatistically significant increases were seen by passing the packed RBCs through either test apparatus unwarmed. Packed RBCs remaining stationary within microwave and countercurrent heating cartridges for 15 mins did show biochemical evidence of hemolysis. Mean plasma hemoglobin increased from 14 +/- 1.7 mg/dL in cold prewarmed units to 57.7 +/- 5.8 mg/dL (p < .05), when warmed in the microwave heating cartridge, and to 55.2 +/- 25 mg/dL (p < .05), when warmed in the countercurrent heat exchanger. Outlet Temperature Studies. Part II: The in-line 900-watt microwave device warmed cold units from a mean inlet temperature of 8.3 +/- 0.3 degrees C to a mean outlet temperature of 31.8 +/- 0.5 degrees C within 5 secs at a mean flow rate of 556 mL/min. At 30 secs, the mean outlet temperature was 33.9 +/- 0.4 degrees C (mean inlet temperature = 9.6 +/- 0.2 degrees C) for microwave warmed packed RBCs as compared with 32.1 +/- 0.5 degrees C (mean inlet temperature = 9.6 +/- 0.3 degrees C) in countercurrent water bath warmed blood (p < .05). From 20 to 30 secs, the packed RBCs warmed by microwave were statistically warmer than the countercurrent water bath warmed packed RBCs.
a) Both in-line countercurrent warming and in-line microwave warming were associated with small increases in parameters of red cell damage representing statistically and clinically insignificant hemolysis. b) Blood sitting in any blood warming device is subject to statistically significant but clinically irrelevant increases in those parameters. c) At high-flow rates, the in-line microwave device warmed blood to higher outlet temperatures than the single channel countercurrent water bath warmer. This method may represent a clinical blood warming modality of the near future.
验证两个假设:a)对有效期内的冷藏红细胞(RBC)进行在线微波加热不会产生显著溶血;b)与当前血液加热技术相比,在高流速(>250 mL/分钟)下,在线微波加热能达到更高的出口温度。
多部分、随机、对照研究。
大型大学医学中心的外科研究实验室。
24单位冷藏的、有效期内可用于输血的红细胞,储存时间为6至16天。
第一部分:微波装置出口,加热与未加热。将6单位冷藏红细胞分成配对样本,以13 mL/分钟的速度通过700瓦在线微波测试装置输注。一对样本加热至37摄氏度;另一对不加热(对照)。在出口处对血液进行分析。第二部分:微波和逆流加热,入口与出口。对12单位冷藏红细胞在模拟输血前(入口)和输血后(出口)进行生化分析。6单位红细胞以>500 mL/分钟的速度通过900瓦在线微波测试装置输注。另外6个单独的冷藏单位使用单通道逆流水浴加热以该速度升温。第三部分:微波和逆流技术,入口与出口,加热与未加热。a)6单位冷藏红细胞也进行生化分析,并以5 mL/分钟的速度通过微波或逆流水浴加热器输注。b)将a部分中使用的单位的红细胞在带有激活加热元件的微波加热盒中静置15分钟。使用逆流血液加热器进行平行静置流动研究。也测试了未加热的对照样本。
第一部分:微波加热和未加热的红细胞在溶血参数上无统计学差异。第二部分:在高流速下,与预热的冷藏对照相比,在线微波或逆流水浴加热后溶血参数无统计学增加。第三部分:在低流速下,未加热的红细胞通过任一测试装置后溶血参数有非统计学意义的增加。红细胞在微波和逆流加热盒中静置15分钟确实显示出溶血的生化证据。当在微波加热盒中加热时,平均血浆血红蛋白从冷藏预热单位的14±1.7 mg/dL增加到57.7±5.8 mg/dL(p<.05),当在逆流热交换器中加热时增加到55.2±25 mg/dL(p<.05)。出口温度研究。第二部分:900瓦在线微波装置在平均流速556 mL/分钟下,在5秒内将冷藏单位的平均入口温度从8.3±0.3摄氏度加热到平均出口温度31.8±0.5摄氏度。在30秒时,微波加热的红细胞的平均出口温度为33.9±0.4摄氏度(平均入口温度=9.6±0.2摄氏度),而逆流水浴加热的血液为32.1±0.5摄氏度(平均入口温度=9.6±0.3摄氏度)(p<.05)。在20至30秒之间,微波加热的红细胞在统计学上比逆流水浴加热的红细胞更温暖。
a)在线逆流加热和在线微波加热均与红细胞损伤参数的小幅增加相关,代表统计学上和临床上无显著意义的溶血。b)血液在任何血液加热装置中静置时,这些参数会有统计学上显著但临床上无关紧要的增加。c)在高流速下,在线微波装置将血液加热到比单通道逆流水浴加热器更高的出口温度。这种方法可能代表了不久的将来的一种临床血液加热方式。